Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:18 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 507486 | NSE: CAPRO

Caprolactam Chemicals Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹53.43Undervalued by 24.26%vs CMP ₹43.00

P/E (41.2) × ROE (13.7%) × BV (₹11.60) × DY (2.00%)

₹37.37Overvalued by 13.09%vs CMP ₹43.00
MoS: -15.1% (Negative)Confidence: 54/100 (Moderate)Models: 2 Under, 6 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹73.1827%Under (+70.2%)
Graham NumberEarnings₹16.4816%Over (-61.7%)
DCFCash Flow₹5.9413%Over (-86.2%)
Net Asset ValueAssets₹11.559%Over (-73.1%)
EV/EBITDAEnterprise₹34.4011%Over (-20%)
Earnings YieldEarnings₹10.409%Over (-75.8%)
ROCE CapitalReturns₹75.7011%Under (+76%)
Revenue MultipleRevenue₹14.646%Over (-66%)
Consensus (8 models)₹37.37100%Overvalued
Key Drivers: EPS CAGR 37.0% lifts DCF — verify sustainability. | Wide model spread (₹6–₹76) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 37.0%

*Investments are subject to market risks

Investment Snapshot

61
Caprolactam Chemicals Ltd scores 61/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health41/100 · Moderate
ROCE 0.5% WeakROE 13.7% GoodD/E 0.52 ModerateInterest Coverage 0.0x RiskyProfitable 3/5 years Mixed
Smart Money50/100 · Moderate
Promoter holding at 54.5% Stable
Earnings Quality75/100 · Strong
OPM expanding (10% → 27%) ImprovingWorking capital: -315 days (improving) Efficient
Quarterly Momentum80/100 · Strong
Revenue (4Q): +39% YoY AcceleratingOPM: 43.4% (up 22.8% YoY) Margin expansion
Industry Rank60/100 · Moderate
P/E 41.2 vs industry 38.4 In-lineROCE 0.5% vs industry 7.1% Below peersROE 13.7% vs industry 8.1% Above peers3Y sales CAGR: 48% High growth

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:18 am

Market Cap 19.8 Cr.
Current Price 43.0
Intrinsic Value₹37.37
High / Low 81.0/37.5
Stock P/E41.2
Book Value 11.6
Dividend Yield0.00 %
ROCE0.48 %
ROE13.7 %
Face Value 10.0
PEG Ratio1.11

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Caprolactam Chemicals Ltd

Competitors

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Caprolactam Chemicals Ltd 19.8 Cr. 43.0 81.0/37.541.2 11.60.00 %0.48 %13.7 % 10.0
Chemfab Alkalis Ltd 469 Cr. 326 906/27047.5 2880.38 %5.89 %3.69 % 10.0
Tata Chemicals Ltd 15,458 Cr. 607 1,027/58056.8 8771.81 %3.96 %1.20 % 10.0
GHCL Ltd 4,093 Cr. 445 668/4198.07 3962.70 %24.2 %18.6 % 10.0
Standard Industries Ltd 78.9 Cr. 12.3 22.8/11.7 20.44.49 %7.81 %10.5 % 5.00
Industry Average6,090.75 Cr337.3838.39392.002.01%7.11%8.14%9.17

All Competitor Stocks of Caprolactam Chemicals Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 2.372.222.061.971.491.441.121.712.291.612.562.362.56
Expenses 1.281.511.301.521.200.770.871.141.821.381.511.701.45
Operating Profit 1.090.710.760.450.290.670.250.570.470.231.050.661.11
OPM % 45.99%31.98%36.89%22.84%19.46%46.53%22.32%33.33%20.52%14.29%41.02%27.97%43.36%
Other Income 0.00-0.010.150.000.000.030.000.000.010.000.000.020.00
Interest 0.140.150.140.130.110.120.140.140.170.180.180.190.18
Depreciation 0.330.390.370.390.400.420.380.400.400.410.380.390.41
Profit before tax 0.620.160.40-0.07-0.220.16-0.270.03-0.09-0.360.490.100.52
Tax % -17.74%0.00%25.00%-28.57%-31.82%31.25%0.00%0.00%-66.67%25.00%24.49%-20.00%17.31%
Net Profit 0.740.170.30-0.06-0.160.12-0.270.04-0.03-0.450.360.130.44
EPS in Rs 1.610.370.65-0.13-0.350.26-0.590.09-0.07-0.980.780.280.96

Last Updated: March 3, 2026, 11:34 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 2:10 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3.922.854.883.234.075.196.516.312.079.846.966.749.09
Expenses 4.032.464.052.763.183.313.994.142.645.174.795.226.04
Operating Profit -0.110.390.830.470.891.882.522.17-0.574.672.171.523.05
OPM % -2.81%13.68%17.01%14.55%21.87%36.22%38.71%34.39%-27.54%47.46%31.18%22.55%33.55%
Other Income 0.01-0.150.400.010.070.070.060.090.410.020.180.010.02
Interest 0.000.060.110.120.190.340.300.300.280.570.500.630.73
Depreciation 0.190.230.510.470.570.971.021.071.031.151.581.591.59
Profit before tax -0.29-0.050.61-0.110.200.641.260.89-1.472.970.27-0.690.75
Tax % -6.90%0.00%14.75%0.00%15.00%23.44%24.60%26.97%-12.93%14.14%29.63%4.35%
Net Profit -0.27-0.060.52-0.120.170.500.950.65-1.282.550.20-0.710.48
EPS in Rs -0.59-0.131.13-0.260.371.092.071.41-2.785.540.43-1.541.04
Dividend Payout % 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)77.78%966.67%-123.08%241.67%194.12%90.00%-31.58%-296.92%299.22%-92.16%-455.00%
Change in YoY Net Profit Growth (%)0.00%888.89%-1089.74%364.74%-47.55%-104.12%-121.58%-265.34%596.14%-391.38%-362.84%

Caprolactam Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:1%
3 Years:48%
TTM:36%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:13%
TTM:78%
Stock Price CAGR
10 Years:24%
5 Years:23%
3 Years:-9%
1 Year:-12%
Return on Equity
10 Years:10%
5 Years:6%
3 Years:14%
Last Year:-14%

Last Updated: September 5, 2025, 2:51 pm

Balance Sheet

Last Updated: February 1, 2026, 2:31 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 4.594.594.594.594.594.604.604.604.604.604.604.604.60
Reserves -3.08-3.13-2.61-2.73-2.56-2.06-1.10-0.52-1.800.740.950.230.72
Borrowings 0.090.820.951.371.893.582.452.153.765.695.868.729.04
Other Liabilities 0.521.150.981.102.351.291.160.973.770.490.250.741.04
Total Liabilities 2.123.433.914.336.277.417.117.2010.3311.5211.6614.2915.40
Fixed Assets 1.192.922.963.383.566.376.075.505.2610.2210.2910.3110.12
CWIP 0.000.000.000.000.000.000.000.003.960.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 0.930.510.950.952.711.041.041.701.111.301.373.985.28
Total Assets 2.123.433.914.336.277.417.117.2010.3311.5211.6614.2915.40

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -0.131.440.580.541.102.962.181.253.050.861.82-0.62
Cash from Investing Activity + 0.00-2.16-0.56-0.89-0.75-3.78-0.73-0.48-4.75-2.14-1.64-1.60
Cash from Financing Activity + 0.070.680.020.300.330.35-1.43-0.591.331.37-0.322.22
Net Cash Flow -0.06-0.050.05-0.050.68-0.470.020.18-0.370.08-0.140.00
Free Cash Flow -0.13-0.720.02-0.350.34-0.821.450.76-1.70-1.300.17-2.23
CFO/OP 45%369%82%115%128%164%92%80%-591%27%88%-41%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-0.20-0.43-0.12-0.90-1.00-1.700.070.02-4.33-1.02-3.69-7.20

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 25.141.2838.8940.6869.052.8116.8227.195.2925.2233.56152.72
Inventory Days 104.29304.1788.7882.6453.8552.14111.68
Days Payable 43.45861.81799.05344.34173.52111.73119.85
Cash Conversion Cycle 85.971.2838.8940.68-488.58-707.4616.8227.19-256.41-94.45-26.03144.54
Working Capital Days 20.48-189.54-71.80-169.50-232.27-274.28-158.11-106.43-689.44-94.22-267.46-314.64
ROCE %-17.06%11.34%27.64%0.32%10.91%19.52%25.85%19.54%-18.61%40.25%6.86%-0.48%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 52.60%52.60%52.60%52.60%53.97%53.97%53.97%53.99%54.02%54.04%54.05%54.50%
Public 47.39%47.40%47.40%47.40%46.03%46.04%46.03%46.00%45.97%45.95%45.94%45.50%
No. of Shareholders 7,9007,9247,9598,0168,0878,1828,2198,2408,1808,1588,1428,068

Shareholding Pattern Chart

No. of Shareholders

Caprolactam Chemicals Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -1.540.435.54-2.791.41
Diluted EPS (Rs.) -1.540.435.54-2.791.41
Cash EPS (Rs.) 1.913.878.05-0.533.73
Book Value[Excl.RevalReserv]/Share (Rs.) 10.5012.0611.616.088.87
Book Value[Incl.RevalReserv]/Share (Rs.) 10.5012.0611.616.088.87
Revenue From Operations / Share (Rs.) 14.6515.1221.394.5013.72
PBDIT / Share (Rs.) 3.335.1110.20-0.354.90
PBIT / Share (Rs.) -0.111.677.69-2.602.58
PBT / Share (Rs.) -1.490.596.46-3.201.94
Net Profit / Share (Rs.) -1.540.425.54-2.791.41
PBDIT Margin (%) 22.7533.8147.66-7.8735.72
PBIT Margin (%) -0.8111.0735.95-57.8818.83
PBT Margin (%) -10.143.9130.18-71.2414.12
Net Profit Margin (%) -10.512.8325.89-61.9710.31
Return on Networth / Equity (%) -14.673.5547.70-45.8215.94
Return on Capital Employeed (%) -1.1210.6244.09-21.5229.13
Return On Assets (%) -4.961.6922.12-12.409.30
Long Term Debt / Equity (X) 0.000.290.490.980.00
Total Debt / Equity (X) 1.801.061.061.340.52
Asset Turnover Ratio (%) 0.510.600.900.230.90
Current Ratio (X) 0.380.240.340.210.53
Quick Ratio (X) 0.340.220.310.180.50
Inventory Turnover Ratio (X) 28.476.315.534.830.13
Interest Coverage Ratio (X) 2.444.738.26-0.587.58
Interest Coverage Ratio (Post Tax) (X) -0.121.405.49-3.643.19
Enterprise Value (Cr.) 28.9429.4729.5425.4116.72
EV / Net Operating Revenue (X) 4.294.243.0012.282.65
EV / EBITDA (X) 18.8812.536.30-156.027.42
MarketCap / Net Operating Revenue (X) 3.013.402.4510.542.39
Price / BV (X) 4.214.274.517.793.70
Price / Net Operating Revenue (X) 3.013.412.4510.542.39
EarningsYield -0.030.010.10-0.050.04

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Caprolactam Chemicals Ltd. is a Public Limited Listed company incorporated on 18/11/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH1988PLC049683 and registration number is 049683. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 6.74 Cr. and Equity Capital is Rs. 4.60 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Chemicals - Inorganic - Caustic Soda/Soda AshB-31, MIDC, Mahad, Raigad District Maharashtra 402302Contact not found
Management
NamePosition Held
Mrs. Zaver Shankarlal BhanushaliChairperson & Managing Director
Mr. Siddharth Shankarlal BhanushaliWholeTime Director & CFO
Mr. Viren Jaysukhlal JasaniInd. Non-Executive Director
Mr. Kamlesh Damji JoisherInd. Non-Executive Director
Mrs. Poonam Bhavin BhanushaliInd. Non-Executive Director

FAQ

What is the intrinsic value of Caprolactam Chemicals Ltd and is it undervalued?

As of 16 April 2026, Caprolactam Chemicals Ltd's intrinsic value is ₹37.37, which is 13.09% lower than the current market price of ₹43.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (13.7 %), book value (₹11.6), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd is trading at ₹43.00 as of 16 April 2026, with a FY2026-2027 high of ₹81.0 and low of ₹37.5. The stock is currently near its 52-week low. Market cap stands at ₹19.8 Cr..

How does Caprolactam Chemicals Ltd's P/E ratio compare to its industry?

Caprolactam Chemicals Ltd has a P/E ratio of 41.2, which is above the industry average of 38.39. The premium over industry average may reflect growth expectations or speculative interest.

Is Caprolactam Chemicals Ltd financially healthy?

Key indicators for Caprolactam Chemicals Ltd: ROCE of 0.48 % is on the lower side compared to the industry average of 7.11%. Dividend yield is 0.00 %.

Is Caprolactam Chemicals Ltd profitable and how is the profit trend?

Caprolactam Chemicals Ltd reported a net profit of ₹-1 Cr in Mar 2025 on revenue of ₹7 Cr. Compared to ₹-1 Cr in Mar 2022, the net profit shows a mixed trend.

Does Caprolactam Chemicals Ltd pay dividends?

Caprolactam Chemicals Ltd has a dividend yield of 0.00 % at the current price of ₹43.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Caprolactam Chemicals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE